Statins Reduce Risk Of Alzheimer’s Disease According To New Long-Term Prospective Study

October 26, 2008 | By admin In Cholesterol News |

Nymox Pharmaceutical Corporation (NASDAQ:NYMX) holds U.S. and global patent rights for the use of statin drugs for the prevention and treatment of Alzheimer’s disease (AD), including for patients at risk for AD because of vascular-related risk factors or disease. An important new study has found that ongoing statin drug use was associated with a 67% reduction in the risk of AD (Current Alzheimer Research 2008; 5: 416-421).

Other Related Posts:

  • Cholesterol statin drugs help lower heart attack risk
  • Statins keep working after you don’t take them?
  • Can statins lower the risk of cancer?
  • Statins may reduce periodontal disease severity
  • Use of cholesterol-lowering drugs may reduce cancer risk

    • No Comments

    Leave a reply